Individual investors buy into vaccination bond issue
Japanese investors have snapped up a $223 million bond program to fund vaccination campaigns in developing countries. The idea is that the investors' money will be used to pay for the upfront costs of a campaign and they will be repaid as governments fund the programs. This is the first time that individual investors have bought into a vaccination bond program and it could prove a model for future fundraising efforts in other countries.
In this case, Japanese investors paid as little as $1,270 to buy into the issue from the International Finance Facility for Immunization. In 2006 the first IFFim bond raised $1 billion from institutions in London and underwritten by a group of countries including the UK.
- read the report from the Financial TimesĀ
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

